Amanda Guth, DVM, PhD, is the chief scientific officer for PhotonPharma.
Formulating Autologous Therapies for Cancer
Autologous tumor cells engineered for immune system stimulation can target unique metabolic, genomic, and phenotypic characteristics of cancer cells.